Delivery Order SPE2DB20D1110-SPE2DB23FK44J
- Not listed
- This federal contract award is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $1,865.62. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 25, 2022, with a ceiling value of $9,010.98 and a completion date of February 28, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 9, 2023, with a ceiling value of $2,345.10. The contract has a firm fixed price and is a delivery order with a completion date of March 10, 2023. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on August 11, 2021, with a ceiling value of $2,910.20. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,024.80 and runs through December 10, 2024. This is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The fixed-price delivery order has a ceiling value of $1,640.44 and a completion date of January 26, 2023. The award was made on January 25, 2023, and there was no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a key vendor for...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,364.54 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a firm fixed-price delivery order with an ultimate completion date of August 31, 2023. This award is not associated with a set-aside program, indicating open competition. Amerisourcebergen...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to AmerisourceBergen Drug Corp, has a ceiling value of $1,344.99 and an ultimate completion date of August 22, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. This award is likely part of a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,236.47, is for the delivery of Quillivant XR 25 mg/5 ml suspension medication. It is a firm-fixed price delivery order contract with a completion date of May 10, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication in 180 ml doses to the Defense Logistics Agency (DLA). The contract, valued at $1,270.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 18, 2024. The contract has a completion date of June 20, 2024 and is a firm-fixed price delivery order. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB23FK44JDelivery Order
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corp., a subsidiary of Cencora, Inc., has a ceiling value of $3,671.98 and a completion date of September 27, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and other federal agencies. The contract award was made through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/26/23 |